Ivabradine Fails to Prevent MINS After Surgery 09/01/25
<p>Welcome to <strong>Cardiology Today</strong> – Recorded September 01, 2025. This episode summarizes 1 key cardiology studies on t
<h3>📋 Full Episode Summary</h3>
<p>This episode covers recent research from top journals like NEJM and JACC. Tap ‘more’ for details.</p>
<h3>📚 Featured Articles</h3>
<h4>Article 1: Ivabradine in Patients Undergoing Noncardiac Surgery: a Randomized Controlled Trial.</h4>
<p><strong>Journal:</strong> Circulation</p>
<p><strong>PubMed Link:</strong> <a href=”https://pubmed.ncbi.nlm.nih.gov/40884771″ target=”_blank”>https://pubmed.ncbi.nlm.nih.gov/40884771</a></p>
<p><strong>Summary:</strong> This study investigated ivabradine to prevent myocardial injury after noncardiac surgery. The trial found no significant reduction in MINS with ivabradine compared to placebo, suggesting ivabradine is not effective for this purpose.</p>
<h3>📝 Transcript</h3>
<div style=”background-color: #f8f9fa; padding: 20px; border-radius: 5px; line-height: 1.6;”>
<p><em>Today’s date is September 01, 2025. Welcome to Cardiology Today. Here are the latest research findings.</em></p>
Article number one. Ivabradine in Patients Undergoing Noncardiac Surgery: a Randomized Controlled Trial. This study investigated ivabradine to prevent myocardial injury after noncardiac surgery. The trial found no significant reduction in MINS with ivabradine compared to placebo, suggesting ivabradine is not effective for this purpose.
<p><em>Thank you for listening. Tap ‘more’ for full notes and links.</em></p>
</div>
<h3>🔍 Keywords</h3>
<p>Cardiology, Heart Disease, Clinical Research, NEJM, JACC.</p>
<h3>ℹ️ About</h3>
<p>Concise summaries of cardiovascular research for professionals.</p>
<p><strong>Subscribe</strong> • <strong>Share</strong> • <strong>Follow</strong></p>